Netmed Inc
OTC:NTME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guanhao Biotech Co Ltd
SZSE:300238
|
CN |
Netmed Inc
EPS (Diluted)
Netmed Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Netmed Inc
OTC:NTME
|
EPS (Diluted)
$0
|
CAGR 3-Years
39%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Netmed Inc
Glance View
NetMed, Inc. engages in the research and development of proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. The company is headquartered in Dublin Ohio, Ohio and currently employs 1 full-time employees. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The firm is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The firm is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.
See Also
What is Netmed Inc's EPS (Diluted)?
EPS (Diluted)
-0
USD
Based on the financial report for Jun 30, 2002, Netmed Inc's EPS (Diluted) amounts to -0 USD.
What is Netmed Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
28%
The average annual EPS (Diluted) growth rates for Netmed Inc have been 39% over the past three years , 28% over the past five years .